Table 2

OR for improvement in VAS back pain, leg pain, and ODI scores ( ≥33% for VAS back pain, ≥40% for VAS leg pain, and ≥30% for ODI) at 12 months after lumbar fusion.

VariablesImprovement in VAS Back PainImprovement in VAS Leg PainImprovement in ODI
Yesa (n = 39)Noa (n = 11)OR (95% CI) P Yesa (n = 42)Noa (n = 7)OR (95% CI) P Yesa (n = 38)Noa (n = 15)OR (95% CI) P
Age, y58 (49–66)47 (42–59)1.04 (0.99–1.10)0.1652 (48–66)47 (39–63)1.04 (0.98–1.11)0.2458 (49–68)50 (42–66)1.02 (0.97–1.06)0.47
Sex
 Female2461.33 (0.35–5.15)0.6828112.0 (1.3–110)0.03*2290.92 (0.27–3.10)0.89
 Male1551 (Reference)1461 (Reference)1661 (Reference)
Smoker
 Yes411 (Reference)0.91411 (Reference)0.70510.47 (0.05–4.41)0.51
 No35100.88 (0.09–8.74)3861.58 (0.15–16.7)33141 (Reference)
Body mass index, kg/m2 28.8 (26.5–33.0)28.2 (23.3–32.3)1.07 (0.92–1.24)0.4028.6 (25.5–33.1)31.2 (30.2–33.0)1.01 (0.85–1.21)0.8930.1 (27.1–33.5)27.1 (22.6–31.7)1.15 (0.99–1.33)0.06
Charlson Comorbidity Index1 (0–2)1 (0–1)1.42 (0.74–2.69)0.291 (0–2)0 (0–2)1.73 (0.74–4.04)0.211.5 (1–2)1 (0–2)1.24 (0.75–2.07)0.41
Number of spinal levels
 11871 (Reference)0.312231 (Reference)0.641970.88 (0.26–2.90)0.83
 22142.04 (0.51–8.12)2040.68 (0.14–3.43)1981 (Reference)
Baseline VAS back pain8 (8–9)7 (5–9)1.56 (1.04–2.35)0.03*8 (7–9)9 (4–10)1.23 (0.81–1.88)0.338 (7–9)9 (7–10)1.01 (0.71–1.44)0.96
Baseline VAS leg pain8 (6–9)7 (3–9)1.16 (0.89–1.51)0.288 (6–9)9 (5–9)0.97 (0.68–1.40)0.898 (6–9)7 (4.5–9)1.10 (0.86–1.41)0.45
Baseline ODI58 (36–64)56 (44–66)0.99 (0.95–1.03)0.6451 (38–64)66 (62–68)0.96 (0.91–1.02)0.1955 (37–65)62 (44–66)0.99 (0.95–1.03)0.66
Baseline NLR2.0 (1.4–2.7)2.0 (1.8–2.1)0.94 (0.69–1.29)0.722.0 (1.6–2.7)1.8 (1.4–2.1)1.62 (0.52–5.00)0.402.0 (1.4–2.7)1.8 (1.4–2.1)1.03 (0.74–1.44)0.87
  • Abbreviations: NLR, neutrophil-lymphocyte ratio; ODI, Oswestry Disability Index; VAS, visual analog scale.

  • a Presented as absolute numbers for categorical variables and median (interquartile range) for quantitative variables. P value determined by binary logistic regression.

  • b Statistically significant at 5% significance level.